Suita, Japan

Toshio Baba

This inventor holds 5 USPTO granted patents. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 1982-1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshio Baba. Retrieved from https://idiyas.com/inventor/toshio-baba-s4e9v8k7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1982-1984

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Toshio Baba: Innovator in Antihypertensive Agents

Introduction

Toshio Baba is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive agents. With a total of 5 patents to his name, Baba's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents are the antihypertensive 4-thiazolidinecarboxylic acids. These compounds, which are derivatives of 4-thiazolidinecarboxylic acid, have been found to be useful in compositions as antihypertensive agents. The general formula for these compounds is represented as ##STR1##, showcasing their potential in treating hypertension.

Career Highlights

Toshio Baba has been associated with Santen Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in antihypertensive medications. His innovative approach and dedication to improving patient outcomes have made him a respected figure in the pharmaceutical industry.

Collaborations

Baba has collaborated with several talented individuals in his field, including Takehisa Chiba and Junichi Iwao. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Toshio Baba's contributions to the field of antihypertensive agents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence the development of effective treatments for hypertension.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…